Cheng‐Le Yin

806 total citations
28 papers, 616 citations indexed

About

Cheng‐Le Yin is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Cheng‐Le Yin has authored 28 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Plant Science. Recurrent topics in Cheng‐Le Yin's work include Natural product bioactivities and synthesis (15 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Phytochemistry and Biological Activities (6 papers). Cheng‐Le Yin is often cited by papers focused on Natural product bioactivities and synthesis (15 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Phytochemistry and Biological Activities (6 papers). Cheng‐Le Yin collaborates with scholars based in Hong Kong, China and Bangladesh. Cheng‐Le Yin's co-authors include Zhihong Cheng, Xiu‐Qiong Fu, Zhi‐Ling Yu, Ji‐Yao Chou, Qin Yan, Ying‐Jie Chen, Jing‐Xuan Bai, Jie Cao, Jun‐Kui Li and Jia‐Ying Wu and has published in prestigious journals such as Scientific Reports, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Cheng‐Le Yin

28 papers receiving 612 citations

Peers

Cheng‐Le Yin
Jin-Mu Yi South Korea
Dae‐Seung Kim South Korea
Byeol Ryu South Korea
Hun Hwan Kim South Korea
Rong Pan China
Joo‐Hui Han South Korea
Jin-Mu Yi South Korea
Cheng‐Le Yin
Citations per year, relative to Cheng‐Le Yin Cheng‐Le Yin (= 1×) peers Jin-Mu Yi

Countries citing papers authored by Cheng‐Le Yin

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Le Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Le Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Le Yin more than expected).

Fields of papers citing papers by Cheng‐Le Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Le Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Le Yin. The network helps show where Cheng‐Le Yin may publish in the future.

Co-authorship network of co-authors of Cheng‐Le Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Le Yin. A scholar is included among the top collaborators of Cheng‐Le Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Le Yin. Cheng‐Le Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jia‐Ying, Ying‐Jie Chen, Xiu‐Qiong Fu, et al.. (2022). Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling. BMC Complementary Medicine and Therapies. 22(1). 73–73. 20 indexed citations
2.
Hossen, Muhammad Jahangir, Xiu‐Qiong Fu, Ji‐Yao Chou, et al.. (2022). Inhibition of the Akt/NF-κB pathway is involved in the anti-gastritis effects of an ethanolic extract of the rhizome of Atractylodes macrocephala. Journal of Ethnopharmacology. 293. 115251–115251. 16 indexed citations
3.
Liu, Yuxi, Xiaodi Niu, Ying‐Jie Chen, et al.. (2021). Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin. Pharmacological Research. 175. 105983–105983. 30 indexed citations
4.
Yin, Cheng‐Le, Xiu‐Qiong Fu, Ji‐Yao Chou, et al.. (2021). A proprietary herbal drug Young Yum Pill ameliorates chronic fatigue syndrome in mice. Phytomedicine. 88. 153602–153602. 10 indexed citations
5.
Hossen, Muhammad Jahangir, Xiu‐Qiong Fu, Ji‐Yao Chou, et al.. (2021). The anti-inflammatory effects of an ethanolic extract of the rhizome of Atractylodes lancea, involves Akt/NF-κB signaling pathway inhibition. Journal of Ethnopharmacology. 277. 114183–114183. 28 indexed citations
6.
Chen, Ying‐Jie, Yuxi Liu, Jia‐Ying Wu, et al.. (2021). A two-herb formula inhibits hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes. Scientific Reports. 11(1). 3850–3850. 8 indexed citations
7.
Wang, Yaping, Xiu‐Qiong Fu, Cheng‐Le Yin, et al.. (2020). A traditional Chinese medicine formula inhibits tumor growth in mice and regulates the miR-34b/c-Met/β-catenin pathway. Journal of Ethnopharmacology. 260. 113065–113065. 7 indexed citations
8.
Wu, Jia‐Ying, Ying‐Jie Chen, Yuxi Liu, et al.. (2020). Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways. Phytomedicine. 68. 153173–153173. 62 indexed citations
9.
Fu, Xiu‐Qiong, Bin Liu, Yaping Wang, et al.. (2020). Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression. Cell Death and Disease. 11(4). 246–246. 55 indexed citations
10.
Chen, Ying‐Jie, Jia‐Ying Wu, Yuxi Liu, et al.. (2020). A two-herb formula inhibits osteoclastogenesis and suppresses NF-kB and MAPK pathways. Journal of Ethnopharmacology. 252. 112625–112625. 6 indexed citations
11.
Chen, Ying‐Jie, Jia‐Ying Wu, Yuxi Liu, et al.. (2020). An herbal formula inhibits STAT3 signaling and attenuates bone erosion in collagen-induced arthritis rats. Phytomedicine. 76. 153254–153254. 13 indexed citations
12.
Liu, Yuxi, Jing‐Xuan Bai, Ting Li, et al.. (2019). MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma. Phytomedicine. 64. 153084–153084. 13 indexed citations
13.
Zhu, Peili, Zhongyu Zheng, Xiu‐Qiong Fu, et al.. (2019). Arnicolide D exerts anti-melanoma effects and inhibits the NF-κB pathway. Phytomedicine. 64. 153065–153065. 24 indexed citations
14.
Liu, Yuxi, Jing‐Xuan Bai, Ting Li, et al.. (2019). A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment. Pharmacological Research. 142. 115–126. 38 indexed citations
15.
Yin, Cheng‐Le, Tao Su, Xiu‐Qiong Fu, et al.. (2019). Young Yum pill inhibits inflammatory mediators and nuclear factor-kappa B signaling in lipopolysaccharide-stimulated RAW 264.7 macrophages.. PubMed. 39(5). 624–631. 1 indexed citations
16.
Hossen, Muhammad Jahangir, Ji‐Yao Chou, Sumei Li, et al.. (2018). An ethanol extract of the rhizome of Atractylodes chinensis exerts anti-gastritis activities and inhibits Akt/NF-κB signaling. Journal of Ethnopharmacology. 228. 18–25. 39 indexed citations
17.
Zhu, Peili, Xiu‐Qiong Fu, Jun‐Kui Li, et al.. (2018). Antrodia camphorata Mycelia Exert Anti-liver Cancer Effects and Inhibit STAT3 Signaling in vitro and in vivo. Frontiers in Pharmacology. 9. 1449–1449. 21 indexed citations
19.
Yan, Qin, Quan Wen, Jie Cao, et al.. (2015). Flavonol glycosides and other phenolic compounds fromViola tianshanicaand their anti-complement activities. Pharmaceutical Biology. 54(7). 1–8. 21 indexed citations
20.
Yin, Cheng‐Le, Yiqing Wu, Yue Cao, et al.. (2015). Pterocarpans and triterpenoids from Gueldenstaedtia verna. Fitoterapia. 106. 46–54. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026